Panbela Therapeutics, Inc. Repayments of Long-Term Debt
Panbela Therapeutics, Inc. reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-03-24
- Panbela Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Panbela Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Panbela Therapeutics, Inc. repayments of long-term debt for the quarter ending 2020-12-31 was $36.00K, a 54.43% decline year-over-year.
- Panbela Therapeutics, Inc. repayments of long-term debt for the quarter ending 2020-09-30 was $28.00K, a 3.70% increase year-over-year.
- Panbela Therapeutics, Inc. repayments of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Panbela Therapeutics, Inc. repayments of long-term debt for fiscal 2020 was $117.00K, a 27.33% decline from fiscal 2019.
- Panbela Therapeutics, Inc. repayments of long-term debt for fiscal 2019 was $161.00K, a 1050.00% increase from fiscal 2018.
- Panbela Therapeutics, Inc. repayments of long-term debt for fiscal 2018 was $14.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-11 | |||
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $64.00K derived: sum of 2 quarters · filed 2022-03-24 | $91.00K derived: sum of 3 quarters · filed 2022-03-24 | $117.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $55.00K derived: sum of 2 quarters · filed 2021-11-10 | $81.00K 10-Q · filed 2021-11-10 | $160.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $53.00K 10-Q · filed 2021-08-11 | $132.00K derived: sum of 3 quarters · filed 2021-08-11 | $159.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $26.00K 10-Q · filed 2021-05-12 | $105.00K derived: sum of 2 quarters · filed 2021-05-12 | $132.00K derived: sum of 3 quarters · filed 2021-05-12 | $160.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $106.00K derived: sum of 2 quarters · filed 2021-03-25 | $134.00K derived: sum of 3 quarters · filed 2021-03-25 | $161.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $55.00K derived: sum of 2 quarters · filed 2020-11-12 | $82.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $55.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $27.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $14.00K 10-K · filed 2020-03-24 |